HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 262 filers reported holding HAEMONETICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $10,395,000 | +2.5% | 178,976 | -20.8% | 2.39% | +10.5% |
| Q3 2017 | $10,144,000 | -42.1% | 226,076 | -49.0% | 2.16% | -33.9% |
| Q2 2017 | $17,505,000 | -12.6% | 443,269 | -10.2% | 3.27% | -1.9% |
| Q1 2017 | $20,018,000 | -3.0% | 493,419 | -3.9% | 3.33% | -5.9% |
| Q4 2016 | $20,647,000 | +10.0% | 513,619 | -0.9% | 3.54% | -0.1% |
| Q3 2016 | $18,774,000 | +5.4% | 518,487 | -15.6% | 3.55% | +6.8% |
| Q2 2016 | $17,805,000 | – | 614,187 | – | 3.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |